Published in J Antimicrob Chemother on July 01, 1985
Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens. Antimicrob Agents Chemother (1989) 1.10
A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science (2001) 4.53
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol (2001) 3.65
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)]. Pathol Biol (Paris) (1982) 2.18
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis (2012) 2.07
The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A (1995) 1.99
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98
Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother (1992) 1.96
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol (2000) 1.94
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun (1994) 1.77
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. J Antimicrob Chemother (1989) 1.74
Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun (1999) 1.68
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol (1997) 1.65
Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun (1998) 1.61
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect Immun (1996) 1.60
Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J Hosp Infect (1990) 1.56
Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect Immun (1996) 1.54
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest (1995) 1.49
Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol (1994) 1.49
Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci U S A (1995) 1.43
Klebsiella pneumoniae strains more resistant to ceftazidime than to other third-generation cephalosporins. J Antimicrob Chemother (1987) 1.42
Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J Immunol (1998) 1.33
Molecular detection and characterization of yellow fever virus in blood and liver specimens of a non-vaccinated fatal human case. J Med Virol (1997) 1.32
[Distribution of constituent beta-lactamases in Pseudomonas aeruginosa]. Presse Med (1984) 1.30
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis. Chemotherapy (1981) 1.21
Specific detection of fusarium species in blood and tissues by a PCR technique. J Clin Microbiol (1999) 1.19
AGS3, an alpha(1-3)glucan synthase gene family member of Aspergillus fumigatus, modulates mycelium growth in the lung of experimentally infected mice. Fungal Genet Biol (2006) 1.15
Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect Immun (2000) 1.12
Two alpha(1-3) glucan synthases with different functions in Aspergillus fumigatus. Appl Environ Microbiol (2005) 1.11
Variations in biological features of West Nile viruses. Ann N Y Acad Sci (2001) 1.08
Diffuse cutaneous infection caused by a presumed monoxenous trypanosomatid in a patient infected with HIV. Trans R Soc Trop Med Hyg (1996) 1.08
Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother (2000) 1.07
Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. J Infect Dis (1999) 1.03
Murine acariasis: I. Pathological and clinical evidence suggesting cutaneous allergy and wasting syndrome in BALB/c mouse. Res Immunol (1996) 0.97
[The first isolation in France of a strain of Neisseria gonorrhoeae producing penicillinase]. Nouv Presse Med (1979) 0.96
A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J Antimicrob Chemother (1992) 0.95
Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann N Y Acad Sci (1994) 0.95
Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB/c mice: localization and characterization. Cell Microbiol (2000) 0.94
Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother (1994) 0.94
[Antibiotic sensitivity of 140 strains of Shigella isolated in Djibouti]. Bull Soc Pathol Exot (1993) 0.93
Evaluation of the placental environment with a new in vitro model of histocultures of early and term placentae: determination of cytokine and chemokine expression profiles. Placenta (2005) 0.92
Comparison of phenotypic methods and DNA hybridization for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1994) 0.91
[Impact of building a dam on the transmission of malaria. Malaria survey conducted in southeast Mauritania]. Bull Soc Pathol Exot Filiales (1986) 0.90
[Value of the E-test for the determination of the susceptibility to antibiotics of Neisseria meningitidis]. Pathol Biol (Paris) (1994) 0.88
Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: an approach to study the role of vimentin in tumorigenesis. J Cell Sci (2000) 0.88
In-vitro antibacterial activity of cefepime: a multicentre study. J Antimicrob Chemother (1993) 0.87
[Cutaneous Alternaria infectoria infection after liver transplantation]. Ann Pathol (1998) 0.87
Antigenic variation of Borrelia turicatae Vsp surface lipoproteins occurs in vitro and generates novel serotypes. Res Microbiol (2000) 0.87
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87
[Cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002]. Arch Inst Pasteur Madagascar (2003) 0.87
beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics. Chemioterapia (1985) 0.87
Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ. Mycoses (1994) 0.86
Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol (2008) 0.86
[The lymphocyte transformation test with the bedsonian antigen (bedsonian LTT) in old and recent Fiessinger-Leroy-Reiter syndromes and in ankylsoing spondylarthritis. Additional study]. Rev Rhum Mal Osteoartic (1976) 0.86
Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. Am J Respir Cell Mol Biol (1999) 0.86
[Disseminated histoplasmosis detected by lingual and tonsillar erosions in an immunocompetent patient]. Ann Dermatol Venereol (1999) 0.85
Failure of teicoplanin treatment associated with an increase in MIC during therapy of Staphylococcus aureus septicaemia. J Antimicrob Chemother (1992) 0.85
[Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu]. Rev Med Interne (1986) 0.85
[Diagnostic pitfalls in infectious disease pathology]. Ann Pathol (2001) 0.83
[Comparative effect of beta-lactam activity on Pseudomonas aeruginosa as a function of resistance phenotypes]. Presse Med (1984) 0.83
Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer (2000) 0.83
Hyperexpression of ICAM-1 and CD36 in placentas infected with Plasmodium falciparum: a possible role of these molecules in sequestration of infected red blood cells in placentas. Histopathology (2000) 0.82
[A new beta-lactamase (carbenicillinase) in Pseudomonas aeruginosa]. Presse Med (1984) 0.82
Clinical trial of concentrated inactivated polio vaccine in a simplified immunization program. Dev Biol Stand (1981) 0.82
[Adiaspiromycosis, 2 cases of incidental finding]. Ann Pathol (1999) 0.82
Clinical relevance of cagA and vacA gene polymorphisms in Helicobacter pylori isolates from Senegalese patients. Clin Microbiol Infect (2011) 0.82
Diffuse cutaneous leishmaniasis due to Leishmania major in Senegal. Trans R Soc Trop Med Hyg (1996) 0.82
Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. Dev Biol Stand (1981) 0.81
A case of myospherulosis occurring in the perirenal adipose tissue. Pathol Res Pract (1996) 0.81
Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model. Clin Exp Immunol (2002) 0.81
Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology (2001) 0.81
Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol (2000) 0.81
Blockade of CD14 aggravates experimental shigellosis. J Endotoxin Res (2001) 0.81
The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime. Drugs Exp Clin Res (1989) 0.81
Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83). J Antimicrob Chemother (1985) 0.80
Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors. Eur J Clin Microbiol Infect Dis (1994) 0.80
Transferrin is an early marker of hepatic differentiation, and its expression correlates with the postnatal development of oligodendrocytes in mice. J Neurosci Res (1997) 0.80
[Case for diagnosis. Ectopic cutaneous schistosomiasis]. Ann Dermatol Venereol (1998) 0.80
In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibiotics. Microb Drug Resist (1995) 0.80
Cytotoxic T cells in AIDS colonic cryptosporidiosis. J Clin Pathol (2001) 0.80
Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma. Eur Respir J (1999) 0.80
[Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae]. Pathol Biol (Paris) (1995) 0.79
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus]. Ann Dermatol Venereol (2008) 0.79
[Adult T-cell leukemia associated with HTLV-1 in a HIV-2 seropositive African]. Ann Dermatol Venereol (1994) 0.79
[Diffuse lepromatous leprosy disclosed by cutaneous vasculitis. The Lucio phenomenon]. Ann Dermatol Venereol (1996) 0.79
[Polyarthritis in anisakiasis. 1st case]. Presse Med (1984) 0.79
[Sensitivity of Neisseria gonorrhoeae to antibiotics: methodologic considerations]. Bull World Health Organ (1981) 0.79
[In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase]. Pathol Biol (Paris) (1991) 0.79